---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-25-000131"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2025-09-25T23:59:59+00:00"
generated_at: "2026-05-17T05:39:41.278718+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# BioRestorative Therapies shareholders elect directors, approve stock plan amendment, ratify auditor, okay exec pay

## Summary
- Elected Francisco Silva (1.59M for) and David Rosa (1.47M for) as Class II directors; ~3.33M broker non-votes.
- Approved amendment to 2021 Stock Incentive Plan boosting authorized shares from 6.85M to 9.85M (1.34M for, 289K against).
- Ratified CBIZ CPAs as independent auditor for FY2025: 4.72M for, 271K against, 4,864 abstentions.
- Advisory vote on executive compensation passed: 1.54M for, 107K against, 19,855 abstentions.

## SEC filing metadata
- accession: 0001021771-25-000131
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2025-09-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177125000131/0001021771-25-000131-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177125000131/brt91825.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-25-000131
- JSON: https://secwatch.observer/filing/0001021771-25-000131.json
- Plain text: https://secwatch.observer/filing/0001021771-25-000131.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.